A Thorough Understanding of Our Clients Needs:
PharmaZell develops and produces pharmaceutical active ingredients (API), provides services for formulation development and compiles required regulatory documents/dosiers for both the originator and generic pharmaceutical industry. Being a German enterprise with multinational development and production sites as well as a globally acting sales organization we are a long lasting reliable and stable partner for our customers on all continents. We develop tailor made solutions based on a broad and flexible technology platform together with our customers striving to solve their problems efficiently and with full commitment. PharmaZell follows ethical principles and acts responsibly caring about the environment, our business partners and employees.
The Best of Both Worlds:
A technology platform that is as extensive as it is flexible is complemented by intensive and trustbased collaboration with customers that comprises countries and continents. At 4 locations in Germany, Switzerland and India, the Company employs over 600 professionals. Corporate headquarters are located in Raubling, Bavaria, with a sales branch situated in Cleveland, Ohio.
Adding to Our Competitive Edge:
PharmaZell places particular emphasis on continuously optimizing its development and production processes. A culture of innovation is as much one of the Company‘s core values as is acting according to ethical principles with respect to staff, partners, and the environment. R&D departments develop production processes and formulations that are turned into commercial products at high speed and in accordance with market and cost requirements. A continuously adapted supply chain ensures optimal quality and reliable product supply.
With its eyes firmly set on the future, PharmaZell relies on growth. Precisely targeted and continuous investment as well as a permanent optimization process ensures that the company will continuously enhance existing offerings. In addition, staff works at the highest level to develop new, seminal technologies.